Diagnostics(15)
-
A Method to Identify Actively Degraded Proteins (No. T4-1832)
MAPP (Mass Spectrometry Analysis of Proteolytic Peptides) is a groundbreaking technology that isolates and identifies proteins actively degraded by the proteasome, offering an unparalleled and direct view of the "active degradome." This innovative approach provides a sensitive an ... Read more6030 -
Microbiome-Based Prediction, Diagnosis, and Treatment of Relapsing Obesity (No. T4-1805)
A novel gut microbiome-based method has been developed to predict and prevent weight regain after weight loss. ... Read more5659 -
Magnetic resonance imaging (MRI) Of Tissue Fibrosis without Contrast Agent (No. T4-1665)
Cardiac fibrosis, a scarring process that impairs cardiac function and increases the risk of sudden death, remains difficult to detect at early stages with current imaging tools. ... Read more5575 -
Baffinity B-probe: Cell-Surface-Biomarkers Detection Platform (No. T4-2487)
Accurate detection of minimal residual disease (MRD) is critical for predicting relapse in hematological cancers. However, current diagnostic tools often fail when therapeutic antibodies mask target markers, leading to false negatives. ... Read more19239 -
Epilepsy related diagnostics and Treatment (No. T4-2481)
Epilepsy affects ~50 million people worldwide, with 30% suffering from drug-resistant epilepsy (DRE) that drives persistent seizures, high mortality, and frequent misdiagnosis. Current EEG-based diagnostics are expert-dependent, slow, and inconsistent. ... Read more19407
Pages
